EGFR and glioblastoma: Most GBM samples show the presence of different amplified RTKs, primarily, either EGFR (40–50%) or platelet-derived growth factor receptor alpha polypeptide (PDGFRA) (15%) but a small fraction show both (Furnari et al., 2015).